Cosyntropin NDC 0781-3440

NDC codes

FDA NDC Directory

Product NDC (as listed)0781-3440Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00781-3440Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0781-3440-95	00781344095	10 VIAL in 1 CARTON (0781-3440-95) / 1 mL in 1 VIAL (0781-3440-71)Marketed from Jun 29, 2012

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Cosyntropin
Generic name (nonproprietary): cosyntropin
Active ingredients: Cosyntropin — .25 mg/mL
Dosage form: Injection, Powder, Lyophilized, For solution
Route: Intravenous
Labeler: Sandoz Inc
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 202147
Marketing start: Jun 29, 2012
Listing expires: Dec 31, 2026
Other FDA classes: Adrenocorticotropic Hormone (Chemical structure)
Identifiers: Product ID 0781-3440_7e07a53d-7214-4471-859f-059d66318106SPL ID 7e07a53d-7214-4471-859f-059d66318106SPL set ID 1342169c-e214-4f22-8363-1fd45b85d1e8UNII 72YY86EA29
Pharmacologic class: Adrenocorticotropic Hormone

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400781344095 followed by a unit qualifier and the quantity

Package 00781-3440-95. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 10, 2024.

Indications (excerpt from the label)

Cosyntropin for injection is indicated, in combination with other diagnostic tests, for use as a diagnostic agent in the screening of adrenocortical insufficiency in adults and pediatric patients. Cosyntropin for injection is an adrenocorticotropin hormone indicated, in combination with other diagnostic tests, for use as a diagnostic agent in the screening of adrenocortical insufficiency in adults and pediatric patients. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 202147

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 202147
Product	Strength	Form · route	Labeler	Product NDC
Cosyntropin	Cosyntropin .25 mg/mL	Injection, Powder, Lyophilized, For solutionIntravenous	HF Acquisition Co LLC, DBA HealthFirst	51662-1567
Cosyntropin	Cosyntropin .25 mg/mL	Injection, Powder, Lyophilized, For solutionIntravenous	Medical Purchasing Solutions, LLC	71872-7313